We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals
IRWD

129 hedge funds and large institutions have $1.02B invested in Ironwood Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 129 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

348% more call options, than puts

Call options by funds: $11.9M | Put options by funds: $2.66M

Holders
129
Holders Change
+129
Holders Change %
–
% of All Funds
4.21%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.1%
New
129
Increased
–
Reduced
–
Closed
–
Calls
$11.9M
Puts
$2.66M
Net Calls
+$9.27M
Net Calls Change
+$9.27M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Axa
26
Axa
France
$4.62M +$6.72M +554,563 New
BA
27
BlackRock Advisors
Delaware
$4.5M +$6.57M +541,670 New
Bank of New York Mellon
28
Bank of New York Mellon
New York
$4.47M +$6.52M +537,787 New
GC
29
Guggenheim Capital
Illinois
$4.15M +$6.04M +498,071 New
Geode Capital Management
30
Geode Capital Management
Massachusetts
$4.08M +$5.94M +489,988 New
Deutsche Bank
31
Deutsche Bank
Germany
$3.87M +$5.65M +465,859 New
TCIM
32
TIAA CREF Investment Management
New York
$3.85M +$5.6M +462,165 New
Caisse de Depot et Placement du Quebec (CDPQ)
33
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$3.68M +$5.35M +441,780 New
Millennium Management
34
Millennium Management
New York
$2.59M +$3.77M +310,955 New
NTCOC
35
Northern Trust Company of Connecticut
Connecticut
$2.57M +$3.75M +309,401 New
BIM
36
BlackRock Investment Management
Delaware
$2.44M +$3.55M +293,000 New
ARTA
37
A.R.T. Advisors
New York
$2.31M +$3.37M +278,054 New
PCA
38
Private Capital Advisors
Connecticut
$2.31M +$3.36M +277,605 New
Charles Schwab
39
Charles Schwab
California
$2.28M +$3.22M +265,289 New
PAMU
40
Pictet Asset Management (UK)
United Kingdom
$2.25M +$3.28M +270,441 New
AG
41
Artal Group
Luxembourg
$2.15M +$3.14M +258,954 New
Goldman Sachs
42
Goldman Sachs
New York
$1.97M +$2.87M +237,079 New
BCB
43
Brian C. Broderick
$1.89M +$2.75M +226,675 New
AllianceBernstein
44
AllianceBernstein
Tennessee
$1.76M +$2.56M +211,338 New
California Public Employees Retirement System
45
California Public Employees Retirement System
California
$1.76M +$2.56M +211,219 New
TRSOTSOK
46
Teachers Retirement System of the State of Kentucky
Kentucky
$1.62M +$2.36M +194,921 New
PC
47
Pier Capital
Connecticut
$1.62M +$2.36M +194,712 New
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$1.61M +$2.35M +193,605 New
Allianz Asset Management
49
Allianz Asset Management
Germany
$1.61M +$2.34M +193,070 New
D.E. Shaw & Co
50
D.E. Shaw & Co
New York
$1.44M +$2.09M +172,193 New
1
2
3 4 5

IRWD Hedge Fund Activity: Q2 2013 in Review

129 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q2 2013, worth a combined $1.02B.

Buyers outnumbered sellers: 129 funds opened new IRWD positions and 0 closed out — a net gain of 129 holders — while 0 added to existing stakes and 0 trimmed.

  • 129 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.02B of Ironwood Pharmaceuticals stock for Q2 2013.
  • 129 funds opened new Ironwood Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +129 holders.

Based on aggregated 13F filings for Q2 2013.